热门资讯> 正文

Vir Biotechnology定价1.5亿美元

2026-02-26 15:22

Vir Biotechnology(VIR) 0
Bullish(BLSH) 0

Vir Biotechnology (VIR) priced its public offering of ~17.65M shares of common stock at $8.50 per share.
Gross proceeds are expected to be about $150M.
The underwriters have a 30-day option to buy up to 2.65M additional shares.
The offering is expected to close on February 27, 2026.
The stock price dropped 2.9% on Wednesday during after-market hours of trading.

More on Vir Biotechnology

Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish
Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript
Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation
Vir Biotechnology launches $200M public stock offering
Vir Biotechnology outlines $1.7B Astellas collaboration and anticipates cash runway into Q2 2028 as VIR-5500 advances

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。